~~<i id='85482F087D'><strike id='85482F087D'><tt id='85482F087D'><pre id='85482F087D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

Wikipedia

author：Wikipedia 2025-09-30 20:35:15 - browse：9

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： FDA approves updated Covid vaccines

explore

hotspot

explore

focus

Wikipedia

knowledge

AdobeAnewstudyofhospitals’charitycarespendingsuggestsnonprofithospitalsreallyaren’tthatdifferentfrom

WSS

Popular nasal decongestant doesn't actually relieve congestion

Food makers tried to stack nutrition panel with preferred experts

FDA approves updated Covid vaccines

New weight loss drugs vying to be the next Wegovy or Mounjaro

New Covid vaccine is recommended for everyone 6 months or older

Telehealth for opioid use disorder is lifesaving

explore

Wikipedia

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Oprah kicked off a national conversation on obesity. Let's have it

Duchenne breakthrough therapy leaves behind pioneering families

Generate Biomedicines machine learning biotech raises $273M

Drug repurposing or repositioning? The language matters

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Hepatitis C has a cure — but many Americans still lack access to it

Will the IRA bring competition to the biologics market?

Drug repurposing or repositioning? The language matters

The Readout: Lenmeldy, GLP

hotspot

New Covid vaccine is recommended for everyone 6 months or older

Hospitals consider fixing cancer drug shortages on their own

How medical schools plan to diversify without affirmative action

Readout LOUD podcast: mifepristone case, GLP

How medical schools plan to diversify without affirmative action

White House touts steps to stem shortages of cancer treatments

explore

focus

Wikipedia

knowledge